9/24
04:26 pm
kapa
Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients [Yahoo! Finance]
High
Report
Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients [Yahoo! Finance]
9/24
04:20 pm
kapa
Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients
Medium
Report
Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients
9/17
04:29 pm
kapa
Kairos Pharma Closing of $6.2 Million Initial Public Offering
Medium
Report
Kairos Pharma Closing of $6.2 Million Initial Public Offering
9/16
10:58 am
kapa
Kairos Pharma Prices $6.2 Million Initial Public Offering [Yahoo! Finance]
High
Report
Kairos Pharma Prices $6.2 Million Initial Public Offering [Yahoo! Finance]
9/16
10:49 am
kapa
Kairos Pharma Prices $6.2 Million Initial Public Offering
High
Report
Kairos Pharma Prices $6.2 Million Initial Public Offering